×
For best experience we recommend to activate Javascript in your browser.
Factor VII antibody (AA 334-452)
The Rabbit Polyclonal anti-Factor VII antibody has been validated for WB, IHC and ELISA. It is suitable to detect Factor VII in samples from Human.
Quick Overview for Factor VII antibody (AA 334-452) (ABIN7572216)
Target
See all Factor VII (F7) Antibodies
Factor VII (F7)
(Coagulation Factor VII (F7))
Reactivity
All reactivities for Factor VII antibodies
Human
Host
All hosts for Factor VII antibodies
Rabbit
Clonality
All clonalities for Factor VII antibodies
Polyclonal
Conjugate
All conjugates for Factor VII antibodies
This Factor VII antibody is un-conjugated
Application
All applications for Factor VII antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-Factor VII Antibody
(hide)
Binding Specificity
All epitopes for Factor VII antibodies
AA 334-452
Purpose
Anti-Human F7 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human F7 (Ala334-Arg452).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for Factor VII
(hide)
Target
Factor VII (F7)
(Coagulation Factor VII (F7))
Alternative Name
Coagulation Factor VII
Background
F7, Proconvertin, SPCA, Serum prothrombin conversion accelerator, Coagulation factor VII, Eptacog alfa
UniProt
P08709
Pathways
Response to Growth Hormone Stimulus , Platelet-derived growth Factor Receptor Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat